{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:10:19Z","timestamp":1649023819178},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.7359","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T22:56:47Z","timestamp":1481756207000},"page":"3623-3626","source":"Crossref","is-referenced-by-count":2,"title":["Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer"],"prefix":"10.2169","volume":"55","author":[{"given":"Takeshi","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Ooguro","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoe","family":"Kurahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Diabetes Therapeutics and Research Center, Tokushima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehide","family":"Matsuhisa","sequence":"additional","affiliation":[{"name":"Diabetes Therapeutics and Research Center, Tokushima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Tokushima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kaltsas G, Alexandraki KI. Adrenal Suppression. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. [cited 2015 Apr 12]. Available from: http:\/\/ncbi.nlm.nih.gov\/books\/NBK279047\/"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomized trials. Lancet 355: 1491-1498, 2000.","DOI":"10.1016\/S0140-6736(00)02163-2"},{"key":"3","unstructured":"3. Dreicer R. Managing advanced prostate cancer: the rapidly changing treatment landscape. Am J Manag Care 20: S282-S289."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Klotz L, Toren P. Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? Curr Oncol 19 (Suppl 3): S13-S21, 2012.","DOI":"10.3747\/co.19.1298"},{"key":"5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1210\/endo-90-5-1238","volume":"90","author":"ML Givner","year":"1972","unstructured":"5. Givner ML, Rochefort JG. Effect of synthetic progestogens and estradiol-17\u03b2 on adrenal function in the rat. Endocrinology 90: 1238-1244, 1972.","journal-title":"Endocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Murakoshi M, Tagawa M, Inada R, Shoji M, Suzuki M, Watanabe K. The effects of new steroidal anti-androgen, TZP-4238, and chlormadinone acetate on the pituitary, prostate and adrenal gland of the rat: histological and immunocytochemical studies. Endocr J 39: 331-340, 1992.","DOI":"10.1507\/endocrj1954.39.331"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Court EA, Watson ADJ, Church DB, Emslie DR. Effects of delmadinone acetate on pituitary-adrenal function, glucose tolerance and growth hormone in male dogs. Aust Vet J 76: 555-560, 1998.","DOI":"10.1111\/j.1751-0813.1998.tb10216.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol. Arch Intern Med 157: 1651-1656, 1997.","DOI":"10.1001\/archinte.1997.00440360053005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Moore NL, Hickey TE, Butler LM, Tilley WD. Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells. Mol Cell Endocrinol 357: 60-70, 2012.","DOI":"10.1016\/j.mce.2011.09.019"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Honer C, Nam K, Fink C, et al. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 5: 1012-1020, 2003.","DOI":"10.1124\/mol.63.5.1012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Schneider HPG. Androgens and antiandrogens. Ann NY Acad Sci 997: 292-306, 2003.","DOI":"10.1196\/annals.1290.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Salvador J, Barberia JJ, Marti J, Forga L, Saavedra J, Moncada E. Time dependency and reversibility of the effects of exclusive cyproterone acetate therapy on pituitary adrenal function in hirsute women. Acta Endocrinol 110: 164-169, 1985.","DOI":"10.1530\/acta.0.1100164"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hellman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima DK. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. J Clin Endocrinol Metab 42: 912-917, 1976.","DOI":"10.1210\/jcem-42-5-912"},{"key":"14","unstructured":"14. Dorner G, Gotz F, Mainz K. Influence of antiandrogens on sexual behavior and gonadal function in male rats. Endocrinol Exp 6: 17-27, 1972."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Geller J, Fruchtman B, Meyer C, et al. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J Clin Endocrinol Metab 27: 556-560, 1967.","DOI":"10.1210\/jcem-27-4-556"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kageyama Y, Kitahara S, Tsukamoto T, et al. Chlormadinone acetate as a possible effective agent for congenital adrenal hyperplasia to suppress elevated ACTH and antagonize masculinization. Endocr J 42: 505-508, 1995.","DOI":"10.1507\/endocrj.42.505"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dluhy RG. Clinical relevance of inhaled corticosteroids and HPA axis suppression. J Allergy Clin Immunol 101: S447-S450, 1998.","DOI":"10.1016\/S0091-6749(98)70157-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/24\/55_55.7359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:57:26Z","timestamp":1498370246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/24\/55_55.7359\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.7359","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}